Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
London, United Kingdom
Countries of investment
  • United Kingdom
Investment stages
  • Pre-Seed
  • Seed
Industries
  • Pharma
  • Diagnostics
  • Biotechnology
  • Health Tech
  • Medical Devices
  • Digital Health
About
Monograph Capital is a distinguished venture capital and private equity firm dedicated to advancing innovative life sciences companies that are poised to transform healthcare. With a team of accomplished professionals, including M.D.s and PhDs, Monograph Capital leverages decades of expertise in biomedical research, clinical medicine, and drug development to identify and support high-potential investments. The firm is committed to fostering the growth of pioneering technologies and therapies that address critical medical challenges, ultimately improving patient outcomes and enhancing the quality of life. Through strategic partnerships and a robust network, Monograph Capital empowers visionary entrepreneurs to realize their impactful solutions in the life sciences sector.
Min check size
$500K
Max check size
$5M
Fund size
NPS

Investment Thesis

Monograph Capital invests in early stage biotech and life sciences companies, with a focus on innovative therapeutic and diagnostic technologies.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

With a strong background in venture capital, the fund manager has successfully led over 30 investments predominantly in the technology and healthcare sectors across North America and Europe. Their operator-first approach emphasizes deep operational insights to drive value creation, resulting in notable exits that include several high-profile acquisitions. Specializing in early to growth-stage investments, they leverage a data-driven strategy to identify transformative opportunities. The manager’s strategic vision has consistently positioned the fund at the forefront of emerging market trends.
Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp